Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network
Authors:
- Isaac S. KohaneIKIsaac S. Kohane
- Undiagnosed Diseases NetworkUNUndiagnosed Diseases Network
- 1 February 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (2) , e2036220
Abstract
Rare and undiagnosed diseases are paradigmatic for the era of precision medicine. Although there is no unique definition for such diseases,1 a disease is typically considered rare if its prevalence is less than 1 per 1250 in the US,2 per 2000 in Europe,3 and per 2500 and 10 000 in Japan and Australia,4 respectively. Many undiagnosed diseases are likely to include a genetic component to their pathogenesis, and yet patients will find themselves on a protracted journey from one specialist to another without diagnosis even in this era of genomic sequencing.5,6 The onset in about half of undiagnosed diseases occurs at birth or during infancy, and these diseases are often associated with premature mortality and disability that is present throughout a patient’s life.1,7-9 According to the Office of Rare Disease Research at the National Institutes of Health, approximately 6% of the inquiries made to the Genetic and Rare Disease Information Center are in reference to an undiagnosed disease.10 In addition, although a large number of rare diseases exist (>7000 different types10), only a small fraction of these diseases (approximately 350 rare diseases) affect more than 80% of all patients with rare diseases.11Keywords
This publication has 16 references indexed in Scilit:
- The Undiagnosed Diseases Network of the National Institutes of HealthJAMA, 2015
- The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and OpportunitiesThe American Journal of Human Genetics, 2015
- Somatoform Disorders and Medically Unexplained Symptoms in Primary CareDeutsches Ärzteblatt international, 2015
- Classification and codification of rare diseasesJournal of Clinical Epidemiology, 2012
- Rare diseases and orphan drugs2011
- Why rare diseases are an important medical and social issueThe Lancet, 2008
- Understanding the narratives of people who live with medically unexplained illnessPatient Education and Counseling, 2005
- Orphan drugs: legal aspects, current situationHaemophilia, 2002
- Reducing waits and delays in the referral process.2002
- Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program.2001